Increased Use of Anti-Tumor Necrosis Factor Following the Implementation of the ECCO–ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease: A Retrospective Single-Center Study

Authors :: Olivier Goulet
Bénédicte Pigneur
Cécile Talbotec
Giulia D'Arcangelo
Frank M. Ruemmele
Elie Nader
Fabienne Charbit-Henrion
Source :: Journal of Pediatric Gastroenterology & Nutrition. 74:79-84
Publication Year :: 2021
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2021.

Subjects :: medicine.medical_specialty
Pediatric Crohn's disease
business.industry
Internal medicine
Pediatrics, Perinatology and Child Health
Gastroenterology
medicine
Tumor necrosis factor alpha
Single Center
business
Outcome (game theory)

Tools